In a 65-year-old man eight weeks post‑coronary artery bypass grafting who was started on amiodarone and apixaban for new atrial fibrillation and is also taking metoprolol, atorvastatin, and aspirin, presenting with generalized weakness, decreased energy, weight loss, bradycardia, delayed relaxation of deep tendon reflexes, and mild depressive symptoms, what is the most likely diagnosis and what is the appropriate initial management?

Amiodarone-Induced Hypothyroidism

This patient has amiodarone-induced hypothyroidism (AIH), and you should immediately check TSH and free T4 levels, discontinue or continue amiodarone based on arrhythmia necessity, and initiate levothyroxine replacement therapy.

Clinical Presentation Analysis

This 65-year-old man presents with a classic constellation of hypothyroid symptoms 8 weeks after starting amiodarone:

• Constitutional symptoms: Weakness, fatigue, decreased energy, poor appetite, 8-pound weight loss
• Neurological findings: Delayed relaxation phase of deep tendon reflexes (pathognomonic for hypothyroidism)
• Cardiovascular: Bradycardia (pulse 54) - compounded by metoprolol
• Psychiatric: Mild depression (PHQ-9) - hypothyroidism commonly presents with depressive symptoms

The timing is critical: AIH typically develops within the first few months of amiodarone therapy 1. Amiodarone contains 37% iodine by weight and causes thyroid dysfunction through multiple mechanisms, with hypothyroidism being more common in iodine-sufficient regions 1.

Immediate Diagnostic Workup

Order these labs immediately:

• TSH (will be elevated in primary hypothyroidism)
• Free T4 (will be low)
• Free T3 (may be low-normal due to amiodarone's inhibition of 5'-deiodinase)
• Anti-thyroid peroxidase antibodies (positive in underlying Hashimoto's thyroiditis)

The delayed relaxation phase of reflexes is highly specific for hypothyroidism and strongly supports this diagnosis even before lab confirmation.

Management Algorithm

Step 1: Assess Amiodarone Necessity

Critical decision point: Can amiodarone be discontinued?

• If atrial fibrillation is controlled and patient is 8 weeks post-CABG: Consider discontinuing amiodarone, as post-operative AF often resolves spontaneously
• If amiodarone must continue: Proceed with levothyroxine replacement while maintaining amiodarone 1

The FDA label notes that amiodarone causes thyroid dysfunction but does not require discontinuation in all cases 2. However, AIH is generally easier to manage than amiodarone-induced thyrotoxicosis 1.

Step 2: Address Bradycardia Contributors

Reduce or discontinue metoprolol temporarily:

• Current pulse of 54 with hypothyroidism and beta-blockade is problematic
• Metoprolol is contributing to fatigue and bradycardia 3
• Once thyroid function normalizes, reassess need for rate control
• The patient's blood pressure (138/70) suggests room to reduce beta-blockade

Step 3: Initiate Thyroid Replacement

Start levothyroxine:

• Initial dose: 25-50 mcg daily (lower dose given age >65 and cardiac history) 3
• Recheck TSH and free T4 in 6-8 weeks
• Titrate by 12.5-25 mcg increments until TSH normalizes
• Target TSH: 0.5-2.5 mIU/L

Step 4: Monitor Closely

Follow-up schedule:

• Repeat thyroid function tests every 6-8 weeks during titration
• Once stable, monitor every 3-6 months while on amiodarone 1, 4
• Reassess depressive symptoms as hypothyroidism resolves (PHQ-9 may improve without antidepressants)

Critical Pitfalls to Avoid

1. Do not attribute symptoms solely to depression: The delayed reflex relaxation phase is pathognomonic for hypothyroidism, not depression
2. Do not continue full-dose metoprolol: This compounds bradycardia and fatigue
3. Do not start high-dose levothyroxine: Elderly patients with coronary disease require cautious initiation (risk of precipitating angina or arrhythmia)
4. Do not assume amiodarone must be stopped: AIH can be managed with levothyroxine replacement while continuing amiodarone if arrhythmia control is essential 1

Anticoagulation Considerations

Continue apixaban for stroke prevention in atrial fibrillation - this is appropriate regardless of thyroid status 5, 6. The patient's CHA2DS2-VASc score is ≥2 (age 65, hypertension, likely heart failure given post-CABG status), making anticoagulation indicated.

Prognosis

With appropriate levothyroxine replacement, expect:

• Symptom improvement within 2-4 weeks
• Normalization of TSH in 6-12 weeks
• Resolution of delayed reflexes, fatigue, and depressive symptoms
• Improved quality of life

The pathogenesis relates to amiodarone's high iodine content causing a failure to escape the Wolff-Chaikoff effect, particularly in patients with underlying thyroid autoimmunity 1. This is a manageable condition that should not prevent appropriate antiarrhythmic therapy if needed.